跨境通(002640.SZ):公司變更為無實控人
格隆匯 4 月 30日丨跨境通(002640.SZ)公佈,公司股東楊建新、樊梅花夫婦與新餘睿景企業管理服務有限公司(“新餘睿景”)於2021年4月30日與廣州開發區新興產業投資基金管理有限公司(“新興基金公司”)簽署了《表決權委託解除協議》,楊建新、樊梅花與新餘睿景解除表決權委託。
此次《表決權委託解除協議》簽署後,新興基金公司對楊建新、樊梅花與新餘睿景合計持有公司228,791,931股股份不再具有支配權,新興基金公司在可支配表決權的股份數量從360,791,931股下降至132,000,000股,可支配表決權比例從23.16%下降至8.47%,此次協議簽署後,公司變更為無實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.